drugset / Trial / NCT00971997
A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose is to evaluate the proportion of subjects achieving a Hemoglobin A1c (HbA1c) level below 6.5%, when lispro mix 50/50 is introduced in a stepwise manner from every day (QD) administration to type 2 diabetic patients who have failed to achieve adequate glycemic control on oral antidiabetic drugs (OADs).
Timeline
- Start
- 2009-09
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lispro Mix 50/50 | Protein / enzyme biologic | — | Subcutaneous |